Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Conjugated Estrogens/Bazedoxifene (Duavee): A Novel Agent for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause And the Prevention of Postmenopausal Osteoporosis.

Literature DB >> 25798038

Conjugated Estrogens/Bazedoxifene (Duavee): A Novel Agent for the Treatment of Moderate-to-Severe Vasomotor Symptoms Associated With Menopause And the Prevention of Postmenopausal Osteoporosis.

Abstract

Conjugated estrogens/bazedoxifene (Duavee): a novel agent for the treatment of moderate-to-severe vasomotor symptoms associated with menopause and the prevention of postmenopausal osteoporosis.

Entities: Chemical Disease

Year: 2015 PMID： 25798038 PMCID： PMC4357350

Source DB: PubMed Journal: P T ISSN： 1052-1372

10 in total

1. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the diagnosis and treatment of menopause.

Authors: Neil F Goodman; Rhoda H Cobin; Samara Beth Ginzburg; Ira A Katz; Dwain E Woode
Journal: Endocr Pract Date: 2011 Nov-Dec Impact factor: 3.443

2. The 2012 hormone therapy position statement of: The North American Menopause Society.

Authors:
Journal: Menopause Date: 2012-03 Impact factor: 2.953

3. Updated 2013 International Menopause Society recommendations on menopausal hormone therapy and preventive strategies for midlife health.

Authors: T J de Villiers; A Pines; N Panay; M Gambacciani; D F Archer; R J Baber; S R Davis; A A Gompel; V W Henderson; R Langer; R A Lobo; G Plu-Bureau; D W Sturdee
Journal: Climacteric Date: 2013-06 Impact factor: 3.005

4. In vitro metabolism, permeability, and efflux of bazedoxifene in humans.

Authors: Li Shen; Syed Ahmad; SeongHee Park; William DeMaio; Aram Oganesian; Theresa Hultin; JoAnn Scatina; Peter Bungay; Appavu Chandrasekaran
Journal: Drug Metab Dispos Date: 2010-06-01 Impact factor: 3.922

5. Effects of bazedoxifene/conjugated estrogens on endometrial safety and bone in postmenopausal women.

Authors: S Mirkin; B S Komm; K Pan; A A Chines
Journal: Climacteric Date: 2012-10-05 Impact factor: 3.005

6. A randomized, placebo- and active-controlled trial of bazedoxifene/conjugated estrogens for treatment of moderate to severe vulvar/vaginal atrophy in postmenopausal women.

Authors: Risa Kagan; R Stan Williams; Kaijie Pan; Sebastian Mirkin; James H Pickar
Journal: Menopause Date: 2010-03 Impact factor: 2.953

7. Endometrial effects of a tissue selective estrogen complex containing bazedoxifene/conjugated estrogens as a menopausal therapy.

Authors: James H Pickar; I-Tien Yeh; Gloria Bachmann; Leon Speroff
Journal: Fertil Steril Date: 2009-07-26 Impact factor: 7.329

8. Breast effects of bazedoxifene-conjugated estrogens: a randomized controlled trial.

Authors: JoAnn V Pinkerton; Jennifer A Harvey; Kaijie Pan; John R Thompson; Kelly A Ryan; Arkadi A Chines; Sebastian Mirkin
Journal: Obstet Gynecol Date: 2013-05 Impact factor: 7.661

9. Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.

Authors: JoAnn V Pinkerton; Wulf H Utian; Ginger D Constantine; Sophie Olivier; James H Pickar
Journal: Menopause Date: 2009 Nov-Dec Impact factor: 2.953

10. Bazedoxifene for the prevention of postmenopausal osteoporosis.

Authors: Luigi Gennari; Daniela Merlotti; Vincenzo De Paola; Giuseppe Martini; Ranuccio Nuti
Journal: Ther Clin Risk Manag Date: 2008-12 Impact factor: 2.423

10 in total

7 in total

1. Bazedoxifene-induced vasodilation and inhibition of vasoconstriction is significantly greater than estradiol.

Authors: Margaret A Zimmerman; Dillion D Hutson; Franck Mauvais-Jarvis; Sarah H Lindsey
Journal: Menopause Date: 2019-02 Impact factor: 2.953

2. Postmenopausal Deep Infiltrating Endometriosis of the Colon: Rare Location and Novel Medical Therapy.

Authors: Benjamin M Snyder; Joseph W Beets; Bruce A Lessey; Samuel R W Horton; Gary A Abrams
Journal: Case Rep Gastrointest Med Date: 2018-02-14

3. Long-Term Administration of Conjugated Estrogen and Bazedoxifene Decreased Murine Fecal β-Glucuronidase Activity Without Impacting Overall Microbiome Community.

Authors: Karen Lee Ann Chen; Xiaoji Liu; Yiru Chen Zhao; Kadriye Hieronymi; Gianluigi Rossi; Loretta Sue Auvil; Michael Welge; Colleen Bushell; Rebecca Lee Smith; Kathryn E Carlson; Sung Hoon Kim; John A Katzenellenbogen; Michael Joseph Miller; Zeynep Madak-Erdogan
Journal: Sci Rep Date: 2018-05-25 Impact factor: 4.379